PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, \'Aghia Sophia\' Children\'s Hospital, Athens, Greece. Electronic address: amichos@med.uoa.gr.\', \'University Research Institute of Maternal and Child Health and Precision Medicine, Athens, Greece.\', \'First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, \'Aghia Sophia\' Children\'s Hospital, Athens, Greece.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(21)00960-910.1016/j.vaccine.2021.07.067
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34400017
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162b2 vaccine.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all